- Home
- LVO vs PEPG Comparison
LVO vs PEPG Comparison
Compare LVO & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- PEPG
- Stock Information
- Founded
- LVO 2009
- PEPG 2018
- Country
- LVO United States
- PEPG United States
- Employees
- LVO N/A
- PEPG N/A
- Industry
- LVO Restaurants
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- LVO Consumer Discretionary
- PEPG Health Care
- Exchange
- LVO Nasdaq
- PEPG Nasdaq
- Market Cap
- LVO 61.3M
- PEPG 52.4M
- IPO Year
- LVO N/A
- PEPG 2022
- Fundamental
- Price
- LVO $0.72
- PEPG $1.50
- Analyst Decision
- LVO Strong Buy
- PEPG Buy
- Analyst Count
- LVO 1
- PEPG 3
- Target Price
- LVO $1.50
- PEPG $9.67
- AVG Volume (30 Days)
- LVO 391.1K
- PEPG 226.6K
- Earning Date
- LVO 05-29-2025
- PEPG 05-08-2025
- Dividend Yield
- LVO N/A
- PEPG N/A
- EPS Growth
- LVO N/A
- PEPG N/A
- EPS
- LVO N/A
- PEPG N/A
- Revenue
- LVO $126,016,000.00
- PEPG N/A
- Revenue This Year
- LVO $0.69
- PEPG N/A
- Revenue Next Year
- LVO N/A
- PEPG N/A
- P/E Ratio
- LVO N/A
- PEPG N/A
- Revenue Growth
- LVO 11.43
- PEPG N/A
- 52 Week Low
- LVO $0.55
- PEPG $0.88
- 52 Week High
- LVO $1.98
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- LVO 51.51
- PEPG 50.35
- Support Level
- LVO $0.67
- PEPG $1.15
- Resistance Level
- LVO $0.76
- PEPG $1.64
- Average True Range (ATR)
- LVO 0.09
- PEPG 0.19
- MACD
- LVO 0.01
- PEPG 0.01
- Stochastic Oscillator
- LVO 33.15
- PEPG 55.56
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.